Waiting for a Cure: Factors Influencing Melanoma Treatment Delays

Le résumé fourni par la source

Melanoma, with a five-year survival rate of 94% in early-stage diagnosis, drops significantly when diagnosed at later stages, making identifying barriers to timely treatment crucial. This literature review examines factors influencing melanoma treatment wait times and their impact on patient outcomes. Elderly, male, and Medicare patients, along with those with higher Breslow thickness and severe melanoma stages, experienced longer wait times. Patients receiving intervention within 30 days had better survival rates. Lack of knowledge and misconceptions about melanoma contribute to delayed care, particularly in communities with lower incidence rates. Black patients faced longer waits from diagnosis to surgery, indicating disparities. Socioeconomic factors also play a role, with lower-income neighborhoods experiencing longer wait times. Targeted interventions are needed to reduce these disparities. Enhancing public health education and addressing patient-based factors can improve outcomes. Further research is required to explore the impact of melanoma across racial groups and investigate factors like insurance coverage and access to care. Community education initiatives could lead to earlier interventions. Understanding these factors is essential for improving access to timely melanoma treatment and enhancing patient outcomes.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.